Major shareholder Artisan Partners has called for a board shake-up at Swiss drugmaker Novartis citing recent clinical trial disappointments and failed acquisitions.
Major shareholder Artisan Partners is pressing for changes at the board of Swiss drugmaker Novartis, according to the company's feed update on Friday.
The request follows what the source described as trial setbacks and acquisition failures at the pharmaceutical giant.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
